DENALI THERAPEUTICS INC.
Ownership & governance
Executives 5Directors 9Avg age 59Avg tenure 6.1y
RW
Ryan Watts
Chief Executive Officer
Age 50Since 2015-07-31Profile →
+13
Executives5
AS
Alexander Schuth
Director of Finance/CFO
Age 52Since 2022-04-30
RW
Ryan Watts→
Chief Executive Officer
Age 50Since 2015-07-31
PC
Peter Chin
Chief Tech/Sci/R&D Officer
Age 58Since 2025-11-05
BZ
Benjamin Zuffi
Chief Tech/Sci/R&D Officer
—Since 2024-07-31
JL
Joe Lewcock
Chief Tech/Sci/R&D Officer
—Since 2019-12-31
Board of directors9
RW
Ryan Watts→
Director/Board Member
Age 50Since 2015-02-28
JF
Jay Flatley→
Director/Board Member
Age 73Since 2015-03-31
DS
David Schenkein→
Director/Board Member
Age 68Since 2015-03-31
SK
Steve Krognes→
Director/Board Member
Age 57Since 2022-04-30
PK
Peter Klein→
Director/Board Member
Age 63Since 2018-03-15
JC
Jennifer Cook→
Director/Board Member
Age 60Since 2018-11-05
NT
Nancy Thornberry→
Director/Board Member
Age 69Since 2021-01-07
JB
Julian Baker→
Chairman
Age 59Since 2025-06-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 7.646 % | 12,135,165 |
| Baillie Gifford & Co. | 7.603 % | 12,066,479 |
| T. Rowe Price Investment Management, Inc. | 5.368 % | 8,519,192 |
| Temasek Holdings Pte Ltd. | 4.419 % | 7,012,974 |
| STATE STREET CORPORATION | 3.952 % | 6,272,001 |
Catalog · 2026-07-09
Registry officers16
| Name | Role | Since | Shares |
|---|---|---|---|
| Julian Baker | Chairman | 2025-06-02 | - |
| David Schenkein | Director/Board Member | 2015-03-31 | - |
| David Schenkein, M.D | Director or executive officer | 2015-04-01 | 197,710 |
| Jay Flatley | Director/Board Member | 2015-03-31 | - |
| Jay Flatley | Director or executive officer | 2015-04-01 | 524,687 |
| Jennifer Cook | Director/Board Member | 2018-11-05 | - |
| Jennifer Cook | Director or executive officer | 2018-11-01 | 173,278 |
| Nancy A. Thornberry | Director or executive officer | 2021-01-01 | 80,761 |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 35.75Range 27–42Analysts 16
27Mean 35.7542
- Strong buy 2
- Buy 17
- Hold 1
Broker actions40 of 115
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | 35 | 2026-08-25 |
| UBS | Maintained | Buy | 34 | 2026-08-07 |
| Morgan Stanley | Maintained | Overweight | 36 | 2026-07-23 |
| Deutsche Bank | Maintained | Buy | 35 | 2026-07-16 |
| Morgan Stanley | Maintained | Overweight | 35 | 2026-05-26 |
| Morgan Stanley | Maintained | Overweight | 40 | 2026-05-14 |
| BTIG | Reiterated | Buy | 39 | 2026-05-11 |
| Wedbush | Maintained | Outperform | 23 | 2026-05-08 |
| Leerink Partners | Maintained | Outperform | 35 | 2026-04-22 |
| Baird | Maintained | Outperform | 34 | 2026-04-07 |
| Morgan Stanley | Maintained | Overweight | 42 | 2026-03-26 |
| Goldman Sachs | Maintained | Buy | 40 | 2026-03-26 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.